Related Experiment Video
Updated: Nov 2, 2025

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Efficacy of Antistaphylococcal Lysin LSVT-1701 in Combination with Daptomycin in Experimental Left-Sided Infective
David B Huang1, Eric Gaukel1, Nancy Kerzee1
1Lysovant Sciences, Inc., New York, New York, USA.
Abstract:
We utilized the rabbit model of aortic valve infective endocarditis to examine the combined efficacy of the lysin LSVT-1701 plus daptomycin. The combination of LSVT-1701 plus daptomycin was highly effective at reducing methicillin-resistant Staphylococcus aureus (MRSA) counts in target tissue. When given for four daily doses, both lysin dose regimens in combination with daptomycin sterilized all target tissues. These findings suggest that LSVT-1701 warrants further clinical evaluation as an adjunctive therapy for the treatment of invasive MRSA infections.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Endocarditis IV: Nursing Management
Mitral Stenosis III: Medical Management
Antimicrobial Effectiveness

